RUMORED BUZZ ON MBL77

mutations provided the fact that, as explained underneath, CLL therapy is predicated within the presence or absence of such mutations. The current consensus is the fact that, besides clonal mutations, subclonal mutations with a variant allelic frequency starting from five to ten% (and so beneath the threshold of detection by common molecular method